Clinical Trial Results:
Phase III (Phase V Program), Open-Label, Randomized, Referred-
Care-Controlled, Clinical Trial to Evaluate the Efficacy and Safety
of MK-0217A/Alendronate Sodium 70 mg/Vitamin D3 5600 I.U.
Combination Tablet on Vitamin D Inadequacy in the Treatment of
Osteoporosis in Postmenopausal Women
Summary
|
|
EudraCT number |
2008-001153-17 |
Trial protocol |
SE DE ES LT GB BE LV FR IE IT |
Global completion date |
20 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jun 2016
|
First version publication date |
02 Jun 2016
|
Other versions |
|
Summary report(s) |
clinicaltrials.gov record including results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.